Aug 16, 2021 04:42 PM (GMT+8) · EqualOcean
Jiuzhou pharmaceutical announced that the company plans to cooperate with Suzhou Huaijin investment management partnership (limited partnership), Hangzhou tiger equity investment partnership (limited partnership), Yunnan Watson Biotechnology Co., Ltd., Chengdu Kanghua Biological Products Co., Ltd., Ningbo Qiaoxin equity investment partnership (limited partnership), Zhang Shaorong, Zibo Chunhan investment partnership (Limited partnership) Ningbo Taide venture capital partnership (limited partnership), Shanghai Sanyou Medical Devices Co., Ltd., Suzhou innovative industry development guidance fund (limited partnership), Suzhou Industrial Park Biological Industry Development Co., Ltd., Kunshan Xinghua Investment Consulting Center (limited partnership), Yangtze River Delta (Jiaxing) strategic emerging industry investment partnership (limited partnership) The Yangtze River Delta synergy industry equity investment partnership (limited partnership) jointly participates in the investment in Suzhou Taifu Huaijin venture capital partnership (limited partnership).